Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Ultragenyx stock (RARE)

Buy Ultragenyx stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Ultragenyx is a biotechnology business based in the US. Ultragenyx shares (RARE) are listed on the NASDAQ and all prices are listed in US Dollars. Ultragenyx employs 1,276 staff and has a trailing 12-month revenue of around $442.6 million.

Our top picks for where to buy Ultragenyx stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Ultragenyx stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RARE. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Ultragenyx stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Ultragenyx stock price (NASDAQ: RARE)

Use our graph to track the performance of RARE stocks over time.

Ultragenyx shares at a glance

Information last updated 2024-07-08.
Latest market close$42.46
52-week range$31.52 - $54.56
50-day moving average $41.22
200-day moving average $42.50
Wall St. target price$89.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-7.95

Is it a good time to buy Ultragenyx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ultragenyx price performance over time

Historical closes compared with the close of $42.46 from 2024-07-10

1 week (2024-07-05) 3.86%
1 month (2024-06-12) -4.88%
3 months (2024-04-12) -9.66%
6 months (2024-01-12) -7.09%
1 year (2023-07-12) -3.39%
2 years (2022-07-12) -35.53%
3 years (2021-07-12) 91.38
5 years (2019-07-12) 58.55

Ultragenyx financials

Revenue TTM $442.6 million
Gross profit TTM $-370,780,000
Return on assets TTM -26.97%
Return on equity TTM -340.05%
Profit margin -138.58%
Book value $1.69
Market Capitalization $3.7 billion

TTM: trailing 12 months

Ultragenyx share dividends

We're not expecting Ultragenyx to pay a dividend over the next 12 months.

Have Ultragenyx's shares ever split?

Ultragenyx's shares were split on a 1:3 basis on 16 January 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ultragenyx shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Ultragenyx shares which in turn could have impacted Ultragenyx's share price.

Ultragenyx share price volatility

Over the last 12 months, Ultragenyx's shares have ranged in value from as little as $31.52 up to $54.56. A popular way to gauge a stock's volatility is its "beta".

RARE.US volatility(beta: 0.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ultragenyx's is 0.56. This would suggest that Ultragenyx's shares are less volatile than average (for this exchange).

Ultragenyx overview

Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co. , Ltd.

Frequently asked questions

What percentage of Ultragenyx is owned by insiders or institutions?
Currently 3.603% of Ultragenyx shares are held by insiders and 88.152% by institutions.
How many people work for Ultragenyx?
Latest data suggests 1,276 work at Ultragenyx.
When does the fiscal year end for Ultragenyx?
Ultragenyx's fiscal year ends in December.
Where is Ultragenyx based?
Ultragenyx's address is: 60 Leveroni Court, Novato, CA, United States, 94949
What is Ultragenyx's ISIN number?
Ultragenyx's international securities identification number is: US90400D1081
What is Ultragenyx's CUSIP number?
Ultragenyx's Committee on Uniform Securities Identification Procedures number is: 90400D108

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site